Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term safety and efficacy of Itopride hydrochloride for functional dyspepsia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itopride hydrochloride (itopride hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED